Skip to main content

Table 3 Prognostic factors of overall survival derived from the univariate and multivariate Cox regression models for all patients and patients who recieved chemotherapy

From: The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments

Variable

All patients (nā€‰=ā€‰65)

Patients who received chemotherapy (nā€‰=ā€‰53)

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

HR(95%CI)

p

HR(95%CI)

p

HR(95%CI)

p

HR(95%CI)

p

With chemo

1.85(0.64ā€“5.28)

.25

      

Tumor size ā‰¦4ā€‰cm (vs >ā€‰4ā€‰cm)

0.61(0.30ā€“1.25)

.18

  

0.86(0.40ā€“1.84)

.69

  

Lymph node metastasis

2.26(1.08ā€“4.74)

.03

  

1.86(0.81ā€“4.28)

0.14

  

FIGO IVB

4.47(1.79ā€“11.20)

<.01

4.78(1.52ā€“15.07)

<.01

4.11(1.60ā€“10.57)

<.01

4.87(1.53ā€“15.54)

<.01

With surgery

0.33(0.16ā€“0.69)

<.01

0.72(0.28ā€“1.85)

.49

0.37(0.17ā€“0.80)

.01

0.74(0.29ā€“1.89)

.53

With chemo (vs without)

3.75(1.22-

   

(vs SCC regimen)

   

Non-SCC regimen

11.53)

.02

2.96(0.87ā€“10.11)

.08

2.90(1.35ā€“6.22)

<.01

3.50(1.53ā€“8.03)

<.01

SCC regimen

1.21(0.39ā€“3.71)

0.74

  

1

 

1

 
  1. SCC small cell carcinoma